These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8929744)

  • 1. No evidence for use of pentoxifylline in acute Kawasaki disease.
    Nash MC; Wade AM
    Eur J Pediatr; 1996 Mar; 155(3):258. PubMed ID: 8929744
    [No Abstract]   [Full Text] [Related]  

  • 2. Pentoxifylline and intravenous gamma globulin combination therapy for acute Kawasaki disease.
    Furukawa S; Matsubara T; Umezawa Y; Motohashi T; Ino T; Yabuta K
    Eur J Pediatr; 1994 Sep; 153(9):663-7. PubMed ID: 7957426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pentoxifylline: brief review and rationale for its possible use in the treatment of autism.
    Gupta S; Rimland B; Shilling PD
    J Child Neurol; 1996 Nov; 11(6):501-4. PubMed ID: 9120235
    [No Abstract]   [Full Text] [Related]  

  • 4. [Recent advance in tumor necrosis factor-α blockade treatment for Kawasaki disease].
    Yan H; Du J
    Zhonghua Er Ke Za Zhi; 2015 Jan; 53(1):73-5. PubMed ID: 25748410
    [No Abstract]   [Full Text] [Related]  

  • 5. [Successful treatment of post circumcision glanular ischemia-necrosis with hyperbaric oxygen and intravenous pentoxifylline].
    Elemen L; Topçu K; Gürcan Nİ; Akay A
    Actas Urol Esp; 2012 Mar; 36(3):200-1. PubMed ID: 21821318
    [No Abstract]   [Full Text] [Related]  

  • 6. Pentoxifylline, ciprofloxacin and prednisone failed to prevent transplant-related toxicities in bone marrow transplant recipients and were associated with an increased incidence of infectious complications.
    Ferrà C; de Sanjosé S; Lastra CF; Martí F; Mariño EL; Sureda A; Brunet S; Gallardo D; Berlanga JJ; García J; Grañena A
    Bone Marrow Transplant; 1997 Dec; 20(12):1075-80. PubMed ID: 9466281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An update on Kawasaki disease II: clinical features, diagnosis, treatment and outcomes.
    Yim D; Curtis N; Cheung M; Burgner D
    J Paediatr Child Health; 2013 Aug; 49(8):614-23. PubMed ID: 23647873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pentoxifylline for slow to resolve hepatopulmonary syndrome post liver transplantation: helpful or unnecessary?
    Aljudaibi B; Qumosani K; Chandok N
    Acta Gastroenterol Belg; 2013 Mar; 76(1):70-1. PubMed ID: 23650789
    [No Abstract]   [Full Text] [Related]  

  • 9. Successful treatment of refractory mucosal leishmaniasis with pentoxifylline plus antimony.
    Lessa HA; Machado P; Lima F; Cruz AA; Bacellar O; Guerreiro J; Carvalho EM
    Am J Trop Med Hyg; 2001 Aug; 65(2):87-9. PubMed ID: 11508396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of infliximab in long-lasting refractory Kawasaki disease.
    Zulian F; Zanon G; Martini G; Mescoli G; Milanesi O
    Clin Exp Rheumatol; 2006; 24(4):453. PubMed ID: 16956440
    [No Abstract]   [Full Text] [Related]  

  • 11. C-reactive protein predicts response to pentoxifylline in patients with idiopathic dilated cardiomyopathy.
    Sliwa K; Woodiwiss A; Libhaber E; Zhanje F; Libhaber C; Motara R; Essop R
    Eur J Heart Fail; 2004 Oct; 6(6):731-4. PubMed ID: 15542408
    [No Abstract]   [Full Text] [Related]  

  • 12. Pentoxifylline. Adjunctive therapy in the treatment of pedal frostbite.
    Hayes DW; Mandracchia VJ; Considine C; Webb GE
    Clin Podiatr Med Surg; 2000 Oct; 17(4):715-22. PubMed ID: 11070801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiproteinuric effect of pentoxifylline in patients with diabetic nephropathy.
    Navarro JF; Mora C
    Diabetes Care; 1999 Jun; 22(6):1006-8. PubMed ID: 10372263
    [No Abstract]   [Full Text] [Related]  

  • 14. Infliximab administration effective in the treatment of refractory Kawasaki disease.
    Accomando S; Liotta A; Maggio MC; Cardella F; Corsello G
    Pediatr Allergy Immunol; 2010 Nov; 21(7):1091-2. PubMed ID: 20977502
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of pentoxifylline treatment on delayed graft function in cadaveric kidney recipients.
    Włodarczyk Z; Oko A; Glyda M; Karczewski M; Idasiak-Piechocka I; Czekalski S
    Transplant Proc; 2000 Sep; 32(6):1382-3. PubMed ID: 10995988
    [No Abstract]   [Full Text] [Related]  

  • 16. Infliximab for intravenous immunoglobulin resistance in Kawasaki disease: a retrospective study.
    Son MB; Gauvreau K; Burns JC; Corinaldesi E; Tremoulet AH; Watson VE; Baker A; Fulton DR; Sundel RP; Newburger JW
    J Pediatr; 2011 Apr; 158(4):644-649.e1. PubMed ID: 21129756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infliximab for intensification of primary therapy for Kawasaki disease: a phase 3 randomised, double-blind, placebo-controlled trial.
    Tremoulet AH; Jain S; Jaggi P; Jimenez-Fernandez S; Pancheri JM; Sun X; Kanegaye JT; Kovalchin JP; Printz BF; Ramilo O; Burns JC
    Lancet; 2014 May; 383(9930):1731-8. PubMed ID: 24572997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Kawasaki disease: what you need to know].
    Bajolle F; Laux D
    Arch Pediatr; 2012 Nov; 19(11):1264-8. PubMed ID: 22921712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Painful ulcers in calciphylaxis - combined treatment with maggot therapy and oral pentoxyfillin.
    Tittelbach J; Graefe T; Wollina U
    J Dermatolog Treat; 2001 Dec; 12(4):211-4. PubMed ID: 12241630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infliximab treatment for refractory Kawasaki syndrome.
    Burns JC; Mason WH; Hauger SB; Janai H; Bastian JF; Wohrley JD; Balfour I; Shen CA; Michel ED; Shulman ST; Melish ME
    J Pediatr; 2005 May; 146(5):662-7. PubMed ID: 15870671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.